- Lutein and Zeaxanthin
- Omega-3 Fatty acids
- Coenzyme Q10
- Flavonoids
- Astaxanthin
- Others
Eye Supplements Market size was valued at USD 2,154.3 million in 2022 and is anticipated to grow at a CAGR of 4.1% over 2023-2029. Eye supplements, also known as ocular supplements or eye vitamins, are dietary supplements formulated to support and promote eye health. These supplements typically contain a combination of vitamins, minerals, antioxidants, and other nutrients that are believed to contribute to maintaining good vision and overall eye function. The aging population plays a significant role in driving the revenues of the eye supplements market. As people age, they are more susceptible to various age-related eye conditions, such as macular degeneration and cataracts, which can impact vision and overall eye health. This demographic shift towards an older population has created a growing demand for eye supplements that are marketed to help reduce the risk of these conditions and support general eye health.
Moreover, increased screen time has become a prevalent aspect of modern lifestyles, with many individuals spending prolonged hours on digital devices such as computers, smartphones, and tablets. This extended screen exposure has led to a rise in digital eye strain and concerns about blue light exposure, which are associated with symptoms like eye fatigue, dryness, and discomfort. In response to these issues, consumers are increasingly turning to eye supplements that claim to offer protection against digital eye strain and blue light. As the reliance on digital devices continues to grow, the demand for eye supplements as a preventive measure against digital eye strain is on the rise, contributing to increased sales in the eye supplements market. However, like any dietary supplement, eye supplements can have side effects or interactions with medications. It's essential for consumers to consult with healthcare professionals before taking such supplements, and this caution can limit sales. Meanwhile, the rising prevalence of eye diseases such as glaucoma and diabetic retinopathy due to factors like diabetes and hypertension can create potential opportunities for the growth of the eye supplements market. Key manufacturers are developing innovative solutions to cater to the end user. For instance, in April 2022, Wellbeing Nutrition launched the world’s first natural eye vitamin, Melts Eye Care to improve eye health and maintain clear vision.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Eye diseases and disorders is one of the biggest healthcare burden for many countries. Growing incidence and prevalence of eye ailments and increase in aging population are driving the growth of the market. For instance, age-related macular degeneration (AMD) condition mainly affects people with age over 50 and responsible for loss of persons central vision. As per the estimates of the National Health Service (NHS) UK, it currently affects more than 0.6 Mn people in the UK and predicted to reach 0.7 Mn by 2020. Furthermore, as a preventive measure various government bodies and companies creates awareness programs about eye health and promotes importance of eye nutrition supplements. For instance, in February 2017, Allergan launched See America public awareness campaign to increase awareness and access to eye examinations. The launch of new pharmaceutical drugs and medical devices that can treat various eye ailments such as cataracts, glaucoma, age-related macular degeneration (AMD), genetic diseases, and others are hampering the growth of market. Furthermore, product recalls from companies due to issues with eye nutrition supplements. For instance, in 2010, Bausch + Lomb (Valeant) recalled its PreserVision Eye Vitamin AREDS 2 Formula in the U.S market due to choking sensations reported in people with age over 70.
The development of new formulations and products of eye supplements stands out as a significant trend within the eye supplements market.
Increase In Livestock Feed Production
The Eye supplements market key players Vitabiotics Ltd. (U.K.), Alliance Pharma plc (U.K.), Efamol Ltd (U.K.), Alcon Laboratories (Novartis AG) (Switzerland), Pfizer Inc. (U.S.), EyeScience (U.S.), The Natures Bounty Co (U.S.), Amway (U.S.), Orthomol (Germany), Biosyntrx Inc. (U.S.), Bausch + Lomb (Valeant) (Canada)
The growing awareness of the importance of eye health and preventive measures and increasing consumers' preference for natural and nutritional eye supplement solutions are some of the key opportunities for companies to enhance their revenue over the forecast years.
1. Executive Summary |
2. Global Eye Supplements Market Introduction |
2.1. Global Eye Supplements Market - Taxonomy |
2.2. Global Eye Supplements Market -Definitions |
2.2.1. By Ingredient Type |
2.2.2. By Source |
2.2.3. By Formulation |
2.2.4. By Distribution Channel |
2.2.5. By Region |
3. Global Eye Supplements Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Eye Supplements Market Dynamic Factors - Impact Analysis |
3.6. Global Eye Supplements Market - Competition Landscape |
4. Global Eye Supplements Market Analysis, 2018-2022 and Forecast, 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Eye Supplements Market, By Ingredient Type, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1. Lutein and Zeaxanthin |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Omega-3 Fatty Acids |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Coenzyme Q10 |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Flavonoids |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Antioxidants |
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Others |
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Eye Supplements Market Forecast, By Source, 2018-2022 and Forecast, 2023-2029 |
6.1. Natural |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Synthetic |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Eye Supplements Market Forecast, By Formulation, 2018-2022 and Forecast, 2023-2029 |
7.1. Tablets |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Capsules |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Liquids |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Eye Supplements Market Forecast, By Distribution Channel, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.1. Hospital Pharmacies |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Retail Pharmacies |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Online Pharmacies |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Eye Supplements Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Eye Supplements Market - Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Region, 2023-2029 |
10. North America Eye Supplements Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.1. Ingredient Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Lutein and Zeaxanthin |
10.1.2. Omega-3 Fatty acids |
10.1.3. Coenzyme Q10 |
10.1.4. Flavonoids |
10.1.5. Antioxidants |
10.1.6. Others |
10.2. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Natural |
10.2.2. Synthetic |
10.3. Formulation Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Tablets |
10.3.2. Capsules |
10.3.3. Liquids |
10.3.4. Others |
10.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Hospital Pharmacies |
10.4.2. Retail Pharmacies |
10.4.3. Online Pharmacies |
10.4.4. Others |
10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. U.S. |
10.5.2. Canada |
10.6. North America Eye Supplements Market - Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2023-2029 |
10.7. North America Eye Supplements Market Dynamics - Trends |
11. 1Europe Eye Supplements Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.1. Ingredient Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Lutein and Zeaxanthin |
11.1.2. Omega-3 Fatty acids |
11.1.3. Coenzyme Q10 |
11.1.4. Flavonoids |
11.1.5. Antioxidants |
11.1.6. Others |
11.2. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Natural |
11.2.2. Synthetic |
11.3. Formulation Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Tablets |
11.3.2. Capsules |
11.3.3. Liquids |
11.3.4. Others |
11.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Hospital Pharmacies |
11.4.2. Retail Pharmacies |
11.4.3. Online Pharmacies |
11.4.4. Others |
11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Poland |
11.5.8. Rest of Europe |
11.6. Europe Eye Supplements Market - Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2023-2029 |
11.7. Europe Eye Supplements Market Dynamics - Trends |
12. Asia-Pacific Eye Supplements Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.1. Ingredient Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Lutein and Zeaxanthin |
12.1.2. Omega-3 Fatty acids |
12.1.3. Coenzyme Q10 |
12.1.4. Flavonoids |
12.1.5. Antioxidants |
12.1.6. Others |
12.2. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Natural |
12.2.2. Synthetic |
12.3. Formulation Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Tablets |
12.3.2. Capsules |
12.3.3. Liquids |
12.3.4. Others |
12.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Hospital Pharmacies |
12.4.2. Retail Pharmacies |
12.4.3. Online Pharmacies |
12.4.4. Others |
12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Eye Supplements Market - Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2023-2029 |
12.7. Asia-Pacific Eye Supplements Market Dynamics - Trends |
13. Latin America Eye Supplements Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
13.1. Ingredient Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Lutein and Zeaxanthin |
13.1.2. Omega-3 Fatty acids |
13.1.3. Coenzyme Q10 |
13.1.4. Flavonoids |
13.1.5. Antioxidants |
13.1.6. Others |
13.2. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Natural |
13.2.2. Synthetic |
13.3. Formulation Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Tablets |
13.3.2. Capsules |
13.3.3. Liquids |
13.3.4. Others |
13.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Hospital Pharmacies |
13.4.2. Retail Pharmacies |
13.4.3. Online Pharmacies |
13.4.4. Others |
13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Argentina |
13.5.4. Rest of Latin America |
13.6. Latin America Eye Supplements Market - Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2023-2029 |
13.7. Latin America Eye Supplements Market Dynamics - Trends |
14. Middle East and Africa Eye Supplements Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
14.1. Ingredient Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Lutein and Zeaxanthin |
14.1.2. Omega-3 Fatty acids |
14.1.3. Coenzyme Q10 |
14.1.4. Flavonoids |
14.1.5. Antioxidants |
14.1.6. Others |
14.2. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Natural |
14.2.2. Synthetic |
14.3. Formulation Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Tablets |
14.3.2. Capsules |
14.3.3. Liquids |
14.3.4. Others |
14.4. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Hospital Pharmacies |
14.4.2. Retail Pharmacies |
14.4.3. Online Pharmacies |
14.4.4. Others |
14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. Israel |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA Eye Supplements Market - Opportunity Analysis Index, By Ingredient Type, Source, Formulation, Distribution Channel, and Country, 2023-2029 |
14.7. MEA Eye Supplements Market Dynamics - Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Ingredient Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Vitabiotics Ltd. (U.K.) |
15.2.2. Alliance Pharma plc (U.K.) |
15.2.3. Efamol Ltd (U.K.) |
15.2.4. Alcon Laboratories (Novartis AG) (Switzerland) |
15.2.5. Pfizer Inc. (U.S.) |
15.2.6. EyeScience (U.S.) |
15.2.7. The Natures Bounty Co (U.S.) |
15.2.8. Amway (U.S.) |
15.2.9. Orthomol (Germany) |
15.2.10. Biosyntrx Inc. (U.S.) |
15.2.11. Bausch + Lomb (Valeant) (Canada) |
16. Research Methodology |
17.Key Assumptions and Acronyms |